In:
Clinical Case Reports, Wiley, Vol. 9, No. 5 ( 2021-05)
Abstract:
Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR.
Type of Medium:
Online Resource
ISSN:
2050-0904
,
2050-0904
Language:
English
Publisher:
Wiley
Publication Date:
2021
detail.hit.zdb_id:
2740234-4